Description
Protect Against Japanese Encephalitis with Ixiaro Vaccine
Ixiaro, the inactivated and adsorbed Japanese encephalitis vaccine, plays a pivotal role in preventing Japanese encephalitis virus (JEV) infection among adults and adolescents aged 17 years and older. This immunization is particularly recommended for individuals residing in or traveling to regions where Japanese encephalitis poses a risk or where recent outbreaks have occurred.
By administering Ixiaro, individuals are exposed to a minute dosage of the virus, prompting the body to mount an immune response and develop protection against the disease. This mechanism allows the immune system to recognize and neutralize the virus effectively, reducing the risk of Japanese encephalitis infection.
Whether you’re a resident of an endemic area or planning to travel to regions with known JEV activity, Ixiaro serves as a critical preventive measure against Japanese encephalitis. Consult your healthcare provider to assess your risk and determine if Ixiaro vaccination is appropriate for you, ensuring peace of mind as you venture into areas where this potentially debilitating virus lurks.
Dosage:
Immunization with Ixiaro consists of 2 doses administered 28 days apart. Immunization series should be completed at least 1 week prior to potential exposure to JEV
